Mitsubishi UFJ Trust & Banking
ORKA

Mitsubishi UFJ Trust & Banking’s Oruka Therapeutics ORKA Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Buy
+2,642
New +$176K ﹤0.01% 1276

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's ORKA Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 2,642 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1276 among its holdings.

76 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 2,642 shares of Oruka Therapeutics worth $251K as of Q2 2026.
  • Oruka Therapeutics was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1276 holding.
  • 76 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.